UK markets open in 3 hours 51 minutes
NIKKEI 225
29,107.98+89.65(+0.31%)HANG SENG
28,715.87+157.28(+0.55%)CRUDE OIL
70.51-0.53(-0.75%)
Genomic Vision Société Anonyme (0QT4.L)
LSE - LSE Delayed price. Currency in EUR
Add to watchlist
1.3740+0.7910 (+135.68%)
At close: 5:05PM BST
| Previous close | 0.5830 |
| Open | 0.5630 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.5626 - 0.5650 |
| 52-week range | 0.5626 - 0.5650 |
| Volume | 16,700 |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | -0.33 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1190 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Genomic Vision Announces the Issuance of 2 New Tranches of Convertible Notes With Warrants (OCABSA) for €2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €12 Million
BAGNEUX, France, Jun 16, 2021--Regulatory News: Genomic Vision (the "Company" - FR0011799907 – GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome, today announces the issuance of the 3rd and 4th tranches of convertible notes with equity warrants attached (OCABSA) for €2 million.
© 2021 Verizon Media. All rights reserved.
